Gabriele ProetzelMS, PhD
Gabriele Proetzel, Ph.D. is Director of Regenerative Medicine at Takeda Pharmaceuticals, based in Cambridge, MA. In her current role, she is focused on cell and gene therapy therapeutic approaches and strategic alliance management.
Prior industry appointments were Chief Scientific Officer at Scil Proteins, Halle Germany, senior scientist Deltagen Inc., San Carlos, California and group leader in the cell biology/musculoskeletal group at Boehringer Mannheim/Roche Penzberg, Germany. Before joining Takeda, Gabriele held the position of Associate Director of Technology Transfer at The Jackson Laboratory, Bar Harbor, Maine, USA.
Gabriele earned her Master degree in Life Sciences from the Ludwig-Maximilian University of Wurzburg, Germany, and a Ph.D. from University of Cincinnati, Ohio studying homologous recombination in embryonic stem cells in order to develop mouse models for disease. She did her postdoctoral training in the laboratory of Prof. Peter Gruss at the Max Planck Institute for Biophysical Chemistry in Gottingen, Germany.